Welcome to our dedicated page for THERAPEUTIC SLTNS INTL news (Ticker: TSOI), a resource for investors and traders seeking the latest updates and insights on THERAPEUTIC SLTNS INTL stock.
Therapeutic Solutions International, Inc. (TSOI) is a cutting-edge biotech company focused on developing innovative immunotherapy solutions. With a strong emphasis on researching and commercializing treatments for various diseases, TSOI is at the forefront of the healthcare industry. Their commitment to improving patient outcomes through groundbreaking therapies sets them apart in the market.
Rhea-AI Summary
Therapeutic Solutions International, Inc. (TSOI) announced the publication of a peer-reviewed paper on personalized immunotherapy for brain cancer. The paper discusses advances in stimulating cancer-specific and patient-specific immunity, integrating immunotherapy with other approaches, and the advantages of mRNA immunization. The company is developing clinical-stage immune-oncology assets through the spin-off Res Nova Biologics, treating cancer patients with its ValloVax and FloraStilbene products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Therapeutic Solutions International's immuno-oncology subsidiary, Res Nova Bio, has successfully treated a patient with FloraStilbene™, a formulation of the abortion pill's active ingredient and pterostilbene.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
-
Rhea-AI Summary
Therapeutic Solutions International subsidiary recruits renowned medical doctor for breast cancer immunotherapy research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Therapeutic Solutions International, Inc. (TSOI) files patent for manufacturing neutrophils that can stop unwanted immune responses while allowing the body to fight bacteria and viruses. Neutrophils generated with IL-10 can block rejection responses and allow for transplantation of therapeutic cells. This could change the biotech industry's approach to immune responses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.33%
Tags
-
Rhea-AI Summary
Therapeutic Solutions International appoints Dr. Navneet Boddu to its Scientific Advisory Board, plans to expand patient access to JadiCells
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Therapeutic Solutions International announces potential breakthrough in cancer immunotherapy
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
Rhea-AI Summary
Therapeutic Solutions International develops new therapeutic approach for treatment of Frontotemporal Dementia
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Res Nova Bio reports findings supporting clinical translation of Pterostilbene-Abortion Pill Cancer Adjuvant. Synergistic suppression of breast cancer growth shown when used with anti-PD1 and anti-CTLA4 antibodies. FloraStilbene™ increases efficacy of standard chemotherapies. Patent application filed. Positive development for non-toxic immunotherapies of breast cancer. Manufacturing and distribution partner secured. Hope for patients with limited options.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Therapeutic Solutions International (TSOI) has achieved a significant production milestone by successfully generating a quality control tested Master Cell Bank of its JadiCell universal donor stem cell product. This allows the company to conduct a Phase III clinical trial with cells possessing FDA-approved characteristics. Previously, the JadiCells demonstrated a 100% reduction in lethality in COVID-19 patients under 85 years old in a Phase I/II clinical trial. The manufacturing of JadiCells in-house by Allogen Biologics will increase the number of patients that can be treated and generate more data in a shorter time period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
Rhea-AI Summary
Therapeutic Solutions International (TSOI) has received a Notice of Allowance from the US Patent and Trademark Office for its patent application on a novel composition of matter for preventing suicide. The company's approach focuses on identifying patients at risk of suicide using immunology-based assays. The patent grant is a significant milestone for the company as it works towards a world without suicide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of THERAPEUTIC SLTNS INTL (TSOI)?
The current stock price of THERAPEUTIC SLTNS INTL (TSOI) is $0.0008 as of November 15, 2024.
What is the market cap of THERAPEUTIC SLTNS INTL (TSOI)?
The market cap of THERAPEUTIC SLTNS INTL (TSOI) is approximately 3.9M.
What is Therapeutic Solutions International, Inc. (TSOI) known for?
TSOI is known for developing cutting-edge immunotherapy solutions for various diseases.
What sets TSOI apart from other biotech companies?
TSOI stands out for its commitment to improving patient outcomes through innovative therapies.
What is the core focus of TSOI's research and development efforts?
The core focus of TSOI's R&D efforts is on developing treatments for a wide range of diseases.
Are there any recent achievements or milestones for TSOI?
TSOI has achieved significant milestones in the biotech industry, leading to advancements in healthcare.
Does TSOI have any notable partnerships in the healthcare sector?
TSOI has established strategic partnerships to enhance its research and commercialization efforts.
How does TSOI contribute to the healthcare industry?
TSOI contributes to the healthcare industry by developing groundbreaking immunotherapy solutions.
What is the overall financial condition of TSOI?
TSOI maintains a strong financial position to support its research and development endeavors.
What products does TSOI offer in the market?
TSOI offers a range of innovative products aimed at improving patient care and outcomes.
What makes TSOI a leader in the biotech industry?
TSOI's dedication to research, innovation, and patient-centric approach positions them as a leader in the biotech sector.
What can investors expect from TSOI in the coming years?
Investors can expect TSOI to continue pioneering advancements in immunotherapy and driving growth in the healthcare market.
THERAPEUTIC SLTNS INTL